نمایش مختصر رکورد

dc.contributor.authorPaul, Sonyen_US
dc.contributor.authorKannan, Iyanaren_US
dc.contributor.authorMohanram, Kalyanien_US
dc.date.accessioned1399-07-09T11:38:27Zfa_IR
dc.date.accessioned2020-09-30T11:38:27Z
dc.date.available1399-07-09T11:38:27Zfa_IR
dc.date.available2020-09-30T11:38:27Z
dc.date.issued2019-09-01en_US
dc.date.issued1398-06-10fa_IR
dc.date.submitted2019-02-09en_US
dc.date.submitted1397-11-20fa_IR
dc.identifier.citationPaul, Sony, Kannan, Iyanar, Mohanram, Kalyani. (2019). Extensive ERG11 mutations associated with fluconazole-resistant Candida albicans isolated from HIV-infected patients. Current Medical Mycology, 5(3), 1-6. doi: 10.18502/cmm.5.3.1739en_US
dc.identifier.issn2423-3439
dc.identifier.issn2423-3420
dc.identifier.urihttps://dx.doi.org/10.18502/cmm.5.3.1739
dc.identifier.urihttp://cmm.mazums.ac.ir/article_96078.html
dc.identifier.urihttps://iranjournals.nlai.ir/handle/123456789/406132
dc.description.abstractBackground and Purpose: Azoles are preferred antifungal agents given their inexpensiveness, limited toxicity, and potentiality of oral administration. However, the extensive use of prophylactic azole therapy for chronic infections, especially in immunocompromised patients, has led to an increase in azole resistance, thereby rising health care costs. Fluconazole resistance is associated with poor clinical outcomes and the emergence of new infections. The present study aimed to investigate the mutations of ERG11 gene in fluconazole-resistant Candida albicans isolates.<br /> Materials and Methods: This study was conducted on 80 clinical samples collected from HIV-infected patients with suspected candidiasis in Tagore Medical College Hospital and Government Hospital of Thoracic Medicine, Chennai, India, for a period of 18 months (May 2016-December 2017). The antifungal susceptibility pattern was determined by agar diffusion and broth dilution techniques as per the Clinical and Laboratory Standards Institute guidelines. The ERG11 gene of the known fluconazole-resistant strains of C. albicans was amplified by polymerase chain reaction (PCR). In addition, the samples were subjected to sequencing and mutation analysis.<br /> Results: A total of 60 Candida species were isolated from HIV patients and were speciated using standard, conventional, and molecular methods. Candida albicans comprised 28.3% (n=17) of the Candida isolates, 59% (n=10) of which were resistant to fluconazole. Sequencing of the amplified product of ERG11 C. albicans gene isolates showed that they were highly mutated and included many nonsense mutations which were not reported earlier.<br /> Conclusion: The molecular characterization of ERG11 gene showed many missense and nonsense mutations. Such mutations, which were unique to the geographical area under investigation, could be concluded to account for the development of resistance to fluconazole.en_US
dc.format.extent580
dc.format.mimetypeapplication/pdf
dc.languageEnglish
dc.language.isoen_US
dc.publisherMazandaran University of Medical Sciencesen_US
dc.relation.ispartofCurrent Medical Mycologyen_US
dc.relation.isversionofhttps://dx.doi.org/10.18502/cmm.5.3.1739
dc.subjectAIDSen_US
dc.subjectAntifungal Resistanceen_US
dc.subjectCandida speciesen_US
dc.subjectCandidiasisen_US
dc.subjectERG11en_US
dc.subjectFluconazoleen_US
dc.subjectMutationen_US
dc.titleExtensive ERG11 mutations associated with fluconazole-resistant Candida albicans isolated from HIV-infected patientsen_US
dc.typeTexten_US
dc.typeOriginal Articlesen_US
dc.contributor.departmentDepartment of Microbiology, Tagore Medical College and Hospital, Rathinamangalam, Chennai, Indiaen_US
dc.contributor.departmentDepartment of Microbiology, Tagore Medical College and Hospital, Rathinamangalam, Chennai, Indiaen_US
dc.contributor.departmentDepartment of Microbiology, Saveetha Medical College and Hospital, Chennai, Indiaen_US
dc.citation.volume5
dc.citation.issue3
dc.citation.spage1
dc.citation.epage6


فایل‌های این مورد

Thumbnail

این مورد در مجموعه‌های زیر وجود دارد:

نمایش مختصر رکورد